三、请说明你公司前期提交A股上市申请的具体情况及撤回原因，是否计划继续推进A股上市及具体安 排，是否存在对本次发行上市产生重大影响的情形。 四、关于本次"全流通"：(1)请列表说明在未行使超额配售权和全额行使超额配售权下，"全流通"前后股 权结构对比情况；(2)请说明国有股东奥普光电参与本次"全流通"的国资管理程序履行情况，并提供对 应国资监管部门的相关政策依据；(3)请说明本次拟参与"全流通"股东所持股份是否存在被质押、冻结 或其他权利瑕疵的情形。 招股书显示，长光辰芯是一家高性能CMOS图像传感器(CIS)提供商。公司一直专注于高性能CMOS图像 传感器的研发，提供九大产品系列，超过50款标准产品，广泛适用于工业成像、科学成像、专业影像和 医疗成像等先进技术领域。 分类来看，公司高性能CMOS图像传感器可以按像素排列分为(i)面阵传感器，及(ii)线阵传感器。面阵传 感器的像素排列呈二维矩阵，使其能够在一次曝光中捕集完整的二维图像。相比之下，线阵传感器的像 素排列呈直线，并通过扫描与传感器方向垂直、并以恒定速度移动的物体来捕集二维图像。 智通财经APP获悉，8月29日，中国证监会公示《境外发行上市备案补充 ...

Group 1 - The China Securities Regulatory Commission (CSRC) has requested additional information from Changguang Chuangxin regarding its equity structure and the transparency of its shareholder Zhuhai Yuncheng [1][2] - Changguang Chuangxin submitted its listing application to the Hong Kong Stock Exchange on June 19, 2025, with CITIC Securities and Guotai Junan International as joint sponsors [1] - The CSRC has outlined specific legal opinions required from lawyers concerning the company's past capital increases, share transfers, and compliance with equity incentive plans [2] Group 2 - Changguang Chuangxin is a high-performance CMOS image sensor (CIS) provider, focusing on the research and development of advanced imaging technologies [3] - The company offers nine product series with over 50 standard products, applicable in various fields such as industrial imaging, scientific imaging, professional imaging, and medical imaging [3] - The high-performance CMOS image sensors are categorized into area array sensors and line array sensors, with area array sensors capturing complete 2D images in one exposure [3]

Core Insights - Changchun has designated optoelectronics as a strategic emerging industry, highlighting its significance in the region's economic development [2][5] - The city currently leads internationally in 12 advanced technology fields, including high-performance CMOS image sensors and new laser technologies [2][5] - By the end of the 14th Five-Year Plan, the number of optoelectronic companies in Changchun is expected to exceed 1,500, with a total output value surpassing 160 billion RMB [2][5] Industry Focus - The key areas for future development in Changchun include semiconductors, satellite technology, and optoelectronic displays [2][5] - The city is recognized as the "cradle of optical science in New China," emphasizing its historical and ongoing contributions to the optical industry [2][5]

Group 1: Company Overview - Changguang Satellite Technology Co., Ltd. is the first commercial remote sensing satellite company in China, achieving multiple records in the aerospace field, including the "one rocket 41 satellites" launch, which set a record for the most satellites launched in a single mission [1] - The company has independently built and operates the world's largest sub-meter commercial remote sensing satellite constellation, "Jilin-1," providing over 150 precision services across 14 sectors, including agriculture, forestry, water conservancy, transportation, and finance [1] Group 2: Industry Development - Changchun City has introduced the "Three-Year Action Plan for the Cultivation of the Optoelectronic Information Industry" to establish the optoelectronic information industry as a new pillar industry following the automotive sector [2] - A total of 83 optoelectronic companies, led by Changchun Changguang Chenxin Microelectronics Co., Ltd., Changchun Changguang Huada Intelligent Manufacturing Sequencing Equipment Co., Ltd., and Changchun Changguang Daqi Technology Co., Ltd., have formed a comprehensive industrial ecosystem covering R&D, design, manufacturing, testing, and application [2] - The optoelectronic information industry has become one of the most strategically emerging industries in Changchun City and Jilin Province, characterized by strong research capabilities, abundant innovative achievements, and significant development potential [2]

Core Viewpoint - Changguang Chenxin, a company specializing in high-performance CMOS image sensors (CIS), is pursuing an IPO in Hong Kong, facing challenges such as declining revenue growth and decreasing profit margins despite a growing market for its core business [2][3]. Group 1: Financial Performance - The company's revenue for 2022, 2023, and 2024 is projected to be CNY 604 million, CNY 604 million, and CNY 673 million, respectively, with adjusted net profits of CNY 293 million, CNY 222 million, and CNY 249 million [2]. - Revenue growth has significantly slowed in 2023 and 2024, with profits experiencing a decline [3]. - The revenue from related transactions with Changchun Institute of Optics, Fine Mechanics and Physics (Changguang Institute) has decreased, contributing only CNY 39 million in 2024, down from CNY 136 million in 2022, representing only 5.79% of total revenue [5]. Group 2: Core Business Challenges - The revenue from the "scientific imaging" segment has declined from CNY 287 million in 2022 to CNY 192 million in 2024, a total drop of 33.1%, despite the market for this segment growing from CNY 800 million to CNY 1.2 billion during the same period [6][7]. - The company's gross margin has decreased from 76.2% in 2022 to 59% in 2024, indicating a significant decline in profitability [8][9]. Group 3: Supply Chain and Industry Position - Changguang Chenxin relies heavily on third-party suppliers for wafer manufacturing, packaging, and testing services, with 77.9% of procurement in 2022 coming from five major suppliers, most of which are foreign companies [12]. - The company has expressed intentions to extend its supply chain by developing in-house packaging capabilities, but progress has been slow, with most packaging still outsourced [13].

Core Viewpoint - The semiconductor industry is experiencing a high level of prosperity driven by the recovery of the terminal consumer market, with companies reporting strong operational performance and growth potential in various segments such as chip design, semiconductor equipment, and packaging and testing [1][10]. Company Overview - Changchun Changguang Chenxin Microelectronics Co., Ltd. (referred to as "Changguang Chenxin") has submitted a listing application to the Hong Kong Stock Exchange, having previously withdrawn its application for the Sci-Tech Innovation Board in January 2025 [2][3]. - The company specializes in high-performance CMOS image sensors (CIS) and offers over 50 standard products across nine product series, applicable in advanced technology fields such as industrial imaging, scientific imaging, professional imaging, and medical imaging [3][10]. Financial Performance - Revenue figures for Changguang Chenxin are as follows: approximately 604 million RMB in 2022, 605 million RMB in 2023, and projected 673 million RMB in 2024. The company has turned a profit, with net income of approximately -84.1 million RMB in 2022, 170 million RMB in 2023, and 197 million RMB in 2024 [3][10]. - The company's high-performance CMOS image sensors are the primary revenue source, contributing approximately 4.02 billion RMB in 2022, 4.10 billion RMB in 2023, and 4.15 billion RMB in 2024, accounting for around 60% of total revenue [4][5]. Product Segmentation - The product segmentation includes high-performance CMOS image sensors, custom sensor solutions, and others. The revenue from custom sensor solutions has significantly increased, from approximately 43.8 million RMB in 2022 to 162 million RMB in 2024, with its revenue share rising from 7.2% to 24.1% [5][8]. - The revenue from line array sensors has declined from 147.3 million RMB in 2022 to 81.8 million RMB in 2024, with the revenue share dropping from 24.4% to 12.2% due to a decrease in average selling prices [4][5]. Industry Trends - The global CIS market is projected to grow from 127.5 billion RMB in 2020 to 139.1 billion RMB in 2024, with a compound annual growth rate (CAGR) of 2.2%. The market is expected to accelerate from 2024 to 2029, reaching an estimated 210.3 billion RMB by 2029, with a CAGR of approximately 8.6% [9][10]. - The demand for CIS is rebounding due to core technological breakthroughs and expanded applications in automotive electronics, medical imaging, and industrial imaging, indicating a structural transformation in the market [9][10].

Core Viewpoint - Changchun Changguang Chenshin Microelectronics Co., Ltd. (referred to as "Changguang Chenshin") has submitted an IPO application to the Hong Kong Stock Exchange after experiencing two consecutive years of losses, achieving profitability in 2023 but failing to list on the Sci-Tech Innovation Board [1][3] Company Overview - Established in 2012, Changguang Chenshin is a leading domestic manufacturer of high-performance CMOS image sensors, primarily serving machine vision, scientific instruments, and professional imaging applications [3][4] - The company offers nine product series with over 50 standard products, applicable in advanced technology fields such as industrial imaging, scientific imaging, professional imaging, and medical imaging [3] Market Position - According to Frost & Sullivan, the global CIS market is expected to grow from 139.1 billion yuan in 2024 to 210.3 billion yuan in 2029, with a compound annual growth rate (CAGR) of approximately 8.6% [3] - In 2024, Changguang Chenshin ranks third globally and first in China for industrial imaging revenue, holding a 15.2% market share, and also ranks third globally and first in China for scientific imaging revenue with a 16.3% market share [3] Financial Performance - The company reported revenues of 198 million yuan, 411 million yuan, and 604 million yuan from 2020 to 2022, with net profits of 59.39 million yuan, -33.17 million yuan, and -83.15 million yuan, respectively, indicating two years of losses [4] - For the reporting period of 2022 to 2024, revenues are projected to be 604 million yuan, 605 million yuan, and 673 million yuan, with net profits of -84.1 million yuan, 170 million yuan, and 197 million yuan, respectively, achieving profitability in 2023 [4][5] Profitability and Margins - The gross margin of Changguang Chenshin decreased from 76.2% to 59% during the reporting period, attributed to declining margins in high-performance CMOS image sensors and custom sensor solutions [5] Leadership and Team - The company is controlled by Wang Xinyang and Zhang Yansha, who collectively hold 49.53% of the shares. Wang serves as the Chairman and CEO, while Zhang is the Vice President and Secretary of the Board [5][6] - The company has a highly educated R&D team, with 401 employees, including 20 PhDs and 181 master's degree holders, making up 50.1% of the workforce [6] Funding and Future Plans - The IPO proceeds will be used to support ongoing R&D and product iteration in key application areas, establish an advanced CMOS image sensor R&D center, expand packaging and testing production lines, and enhance international business operations [8]

Core Viewpoint - Changchun Changguang Chenxin Microelectronics Co., Ltd. (referred to as "Changguang Chenxin") is seeking to go public in the Hong Kong market after previously attempting to list on the Sci-Tech Innovation Board, highlighting its ambition to expand into international capital markets and enhance brand recognition [1][2]. Group 1: Company Background - Changguang Chenxin was established in September 2012 to meet the demand for high-performance CMOS image sensors (CIS) and has undergone multiple rounds of capital increases and share transfers, attracting notable investors such as Aopu Optoelectronics and Hillhouse Capital [2]. - The company transitioned to a joint-stock company on December 26, 2022, and previously submitted an IPO application to the Shanghai Stock Exchange in June 2023, which was later withdrawn in January 2025 [2]. Group 2: Business Overview - Changguang Chenxin is a leading global provider of high-performance CMOS image sensors, offering nine product series and over 50 standard products for various advanced technology fields, including industrial imaging and medical imaging [3]. - The company also provides customized sensor solutions, allowing clients in high-end industrial detection and medical applications to develop next-generation products [3]. Group 3: Financial Performance - Revenue for Changguang Chenxin from 2022 to 2024 is projected to be approximately CNY 604 million, CNY 605 million, and CNY 673 million, respectively, with net profits of approximately -CNY 84.1 million, CNY 170 million, and CNY 197 million [3]. - The gross margin is expected to decline from 76.2% in 2022 to 59.0% in 2024, with adjusted net margins decreasing from 48.5% to 37.0% during the same period, primarily due to falling margins in high-performance CIS and customized sensor solutions [4]. Group 4: Market Position and Challenges - Changguang Chenxin's revenue heavily relies on area array sensors, contributing 66.5%, 67.7%, and 61.6% of total revenue from 2022 to 2024, indicating a potential vulnerability in its product mix [4]. - The company has experienced stagnation in traditional high-performance CIS growth, while customized sensor solutions have seen rapid growth, increasing their revenue contribution from 7.2% in 2022 to 24.1% in 2024 [4]. Group 5: Global Expansion and Inventory Concerns - Changguang Chenxin's sensors have been exported to over 30 countries, with overseas revenue accounting for 26.0% of total revenue in 2024, although this represents a decline from 33.9% in 2022 [5]. - The company's inventory levels have raised concerns, with inventory values reported at CNY 304 million, CNY 373 million, and CNY 287 million from 2022 to 2024, alongside provisions for inventory impairment [5]. Group 6: IPO and Future Plans - Prior to its IPO, Changguang Chenxin announced a dividend of CNY 0.05 per share, totaling CNY 18.5 million, to be paid by August 2025 [6]. - If the IPO is successful, the company plans to use the raised funds for R&D in key application areas, establishing a CMOS sensor R&D center, expanding packaging and testing production lines, and enhancing international business operations [6].

Summary of Key Points Core Viewpoint The article provides an overview of the recent activities in the Hong Kong stock market, highlighting the number of companies that have submitted applications for listing, those that have passed the hearing, and details about their financial performance and market positions. Group 1: New Applications - A total of 19 companies submitted applications to the Hong Kong Stock Exchange from June 16 to June 22 [3] - New Hope Group (600803.SH) is the largest private natural gas company in China, with a market share of approximately 6.1% in 2024 [3] - Wolong Technology (002130.SZ) is the second-largest high-speed copper cable manufacturer globally, holding a 24.9% market share [4] - Beijing Geekplus Technology Co., Ltd. is the largest provider of AMR solutions globally, maintaining its leading position for six consecutive years [5] - Banu International Holdings is the largest hot pot brand in China by revenue, with a market share of 3.1% [6] - Hope Sea Inc. is the largest comprehensive electronic product import supply chain solution provider in China, with an import GMV of approximately RMB 34.8 billion in 2024 [7] - Guangzhou Shiyuan Electronic Technology Co., Ltd. ranks first in the Chinese market for interactive smart panels with a 25.0% market share [8] - Anmai Biotechnology Co., Ltd. ranks second globally in T-cell connector therapy, with total transaction values exceeding USD 2.1 billion [9] - Beijing Haizhi Technology Group focuses on industrial-grade AI solutions, ranking fifth in the Chinese market [10] - Suzhou Jiyi Technology Co., Ltd. ranks second in digital retail operations in China [11] - Drip Irrigation International Investment Co., Ltd. is the first global exchange group based on revenue-sharing models [12] - Zhaowei Electromechanical (003021.SZ) provides integrated micro-drive systems, with revenues projected to grow [13] - Meige Intelligent (002881.SZ) ranks fourth globally in wireless communication modules, holding a 6.4% market share [14] - Yuxin Technology (300674.SZ) is a leading fintech solution provider in China, with significant market shares in various sectors [15] - Shanghai Zhuoyue Ruixin Digital Technology Co., Ltd. ranks second in the digital education market for higher education in China [16] - Zhaoyi Innovation (603986.SH) is the second-largest NOR Flash provider globally, with an 18.5% market share [17] - Changchun Changguang Chenxin Microelectronics Co., Ltd. specializes in high-performance CMOS image sensors [18] - Weichai Lovol Smart Agriculture Technology Co., Ltd. is a leading provider of smart agricultural solutions in China [19] - PPIO is an independent distributed cloud computing service provider [20] - Xiangkang Holdings is a major technical apparel manufacturer for high-end brands [22] Group 2: Companies Passing Hearings - Four companies passed the listing hearing this week, including Fuwai Group, which is a pan-Asian life insurance company with projected insurance revenue growth [24] - Fengcai Technology focuses on chip design for BLDC motor control, ranking sixth in the Chinese market [25] - Xunzhong Communication Technology Co., Ltd. is the third-largest cloud communication service provider in China [26] - Cloudbreak Pharma Inc. is a clinical-stage ophthalmic biotech company with two core products [27] Group 3: Recent IPOs - Haitan Flavor Industry (03288.HK) raised approximately HKD 10.1 billion in its IPO, with a slight decline in stock price post-listing [28] - Sanhua Intelligent (02050.HK) had a strong subscription rate for its IPO [29] - Baize Medical (02609.HK) and other companies also reported significant subscription rates for their IPOs [30][31][32][33]

Market Overview - A-shares experienced a slight decline this week, with the Shanghai Composite Index down 0.51% closing at 3360 points, and the Wind All A Index down 1.07% [1] - Hong Kong stocks mirrored A-shares, with the Hang Seng Index dropping 1.52% and the Hang Seng Tech Index down 2.03% [2] - U.S. stock indices showed mixed performance, with the Dow Jones and Nasdaq rising while the S&P 500 fell [3] Positive Developments - Novo Nordisk announced significant weight loss results from its STEP UP 3b clinical trial, showing a 21% average weight reduction for participants on a higher dose of Wegovy, with one-third achieving over 25% weight loss [3] - Lao Pu Gold opened its first overseas store in Singapore, marking a key step in its global expansion strategy [3] - Zhifei Biological received clinical trial approval for its adsorbed tetanus vaccine, allowing it to proceed with trials [4] - Tencent Cloud launched "AI Builder," enabling users to generate complete applications from simple descriptions, enhancing the app development experience [5] - Xin Xuan Group reported significant sales during the 618 shopping festival, with 12 brands exceeding 100 million in sales and total viewership reaching 550 million [6][7] - Heng Rui Pharmaceutical received approval for six drug clinical trials, including new oral and injectable therapies [8] - Li Auto's first pure electric SUV, the Li i8, is set to launch in late July [9] - Yingmu Technology plans to release a new strategic product in Q3 [10] - Desay SV announced a partnership with Chery Automobile to develop an integrated central computing platform for smart driving [11] Negative Developments - Anker Innovations announced a recall of certain batches of power banks due to quality issues with battery cells [12] - The Shanghai Stock Exchange is monitoring stocks with abnormal trading behaviors, including *ST Yanzhen [13] - Ningbo Huaxiang expects a loss of 273 million to 369 million yuan in the first half of 2025 due to the impact of its European business divestiture [14][15] - *ST Jinguang received a decision to terminate its stock listing, entering a delisting period starting June 30, 2025 [16] - SpaceX's Starship S36 experienced an explosion during a static fire test [17] - Microsoft plans to lay off thousands of employees, primarily in sales [17] - *ST Xinyuan's controlling shareholder is restricted from high consumption due to a contract dispute [17] - *ST Hengli received a decision to terminate its stock listing, with trading resuming on June 25, 2025 [18] - Honda is recalling nearly 259,000 vehicles in the U.S. due to brake pedal issues [19] - Ford is recalling 27,768 vehicles in the U.S. due to a child lock malfunction [19] - Wanda Group's 40 million shares have been frozen [19] - Black Sesame received a warning letter from the Guangxi Securities Regulatory Bureau for governance issues [20][21] - *ST Jiu You announced its stock will be delisted, entering a 15-day trading period before delisting [22] - San Yao Biotech terminated its exclusive agreement with Guoguang Biotech, affecting its flu vaccine distribution in mainland China [23] IPO and Market Activity - Haitian Flavoring's H-shares were priced at HKD 36.3, with additional shares issued [35] - The China Securities Regulatory Commission approved Guangdong Jian Ke's IPO registration for the Growth Enterprise Market [28] - Several companies, including PPIO and PPLabs Technology, submitted IPO applications to the Hong Kong Stock Exchange [26][29] - The Hong Kong Stock Exchange reported that approximately 190 companies are in line to go public [45]